Cargando…
TRI Genotyping and Chemotyping: A Balance of Power
Fusarium is among the top 10 most economically important plant pathogens in the world. Trichothecenes are the principal mycotoxins produced as secondary metabolites by select species of Fusarium and cause acute and chronic toxicity in animals and humans upon exposure either through consumption and/o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076749/ https://www.ncbi.nlm.nih.gov/pubmed/31973043 http://dx.doi.org/10.3390/toxins12020064 |
_version_ | 1783507277050806272 |
---|---|
author | Villafana, Ria T. Ramdass, Amanda C. Rampersad, Sephra N. |
author_facet | Villafana, Ria T. Ramdass, Amanda C. Rampersad, Sephra N. |
author_sort | Villafana, Ria T. |
collection | PubMed |
description | Fusarium is among the top 10 most economically important plant pathogens in the world. Trichothecenes are the principal mycotoxins produced as secondary metabolites by select species of Fusarium and cause acute and chronic toxicity in animals and humans upon exposure either through consumption and/or contact. There are over 100 trichothecene metabolites and they can occur in a wide range of commodities that form food and feed products. This review discusses strategies to mitigate the risk of mycotoxin production and exposure by examining the Fusarium-trichothecene model. Fundamental to mitigation of risk is knowing the identity of the pathogen. As such, a comparison of current, recommended molecular approaches for sequence-based identification of Fusaria is presented, followed by an analysis of the rationale and methods of trichothecene (TRI) genotyping and chemotyping. This type of information confirms the source and nature of risk. While both are powerful tools for informing regulatory decisions, an assessment of the causes of incongruence between TRI genotyping and chemotyping data must be made. Reconciliation of this discordance will map the way forward in terms of optimization of molecular approaches, which includes data validation and sharing in the form of accessible repositories of genomic data and browsers for querying such data. |
format | Online Article Text |
id | pubmed-7076749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70767492020-03-20 TRI Genotyping and Chemotyping: A Balance of Power Villafana, Ria T. Ramdass, Amanda C. Rampersad, Sephra N. Toxins (Basel) Review Fusarium is among the top 10 most economically important plant pathogens in the world. Trichothecenes are the principal mycotoxins produced as secondary metabolites by select species of Fusarium and cause acute and chronic toxicity in animals and humans upon exposure either through consumption and/or contact. There are over 100 trichothecene metabolites and they can occur in a wide range of commodities that form food and feed products. This review discusses strategies to mitigate the risk of mycotoxin production and exposure by examining the Fusarium-trichothecene model. Fundamental to mitigation of risk is knowing the identity of the pathogen. As such, a comparison of current, recommended molecular approaches for sequence-based identification of Fusaria is presented, followed by an analysis of the rationale and methods of trichothecene (TRI) genotyping and chemotyping. This type of information confirms the source and nature of risk. While both are powerful tools for informing regulatory decisions, an assessment of the causes of incongruence between TRI genotyping and chemotyping data must be made. Reconciliation of this discordance will map the way forward in terms of optimization of molecular approaches, which includes data validation and sharing in the form of accessible repositories of genomic data and browsers for querying such data. MDPI 2020-01-21 /pmc/articles/PMC7076749/ /pubmed/31973043 http://dx.doi.org/10.3390/toxins12020064 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Villafana, Ria T. Ramdass, Amanda C. Rampersad, Sephra N. TRI Genotyping and Chemotyping: A Balance of Power |
title | TRI Genotyping and Chemotyping: A Balance of Power |
title_full | TRI Genotyping and Chemotyping: A Balance of Power |
title_fullStr | TRI Genotyping and Chemotyping: A Balance of Power |
title_full_unstemmed | TRI Genotyping and Chemotyping: A Balance of Power |
title_short | TRI Genotyping and Chemotyping: A Balance of Power |
title_sort | tri genotyping and chemotyping: a balance of power |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076749/ https://www.ncbi.nlm.nih.gov/pubmed/31973043 http://dx.doi.org/10.3390/toxins12020064 |
work_keys_str_mv | AT villafanariat trigenotypingandchemotypingabalanceofpower AT ramdassamandac trigenotypingandchemotypingabalanceofpower AT rampersadsephran trigenotypingandchemotypingabalanceofpower |